Shingles, also known as herpes zoster, is a viral infection caused by the reactivation of the varicella-zoster virus, which also causes chickenpox. It is characterized by a painful rash that typically appears on one side of the body or face. The condition can lead to complications such as postherpetic neuralgia (PHN), a persistent pain in the area where the rash occurred, even after it has healed. To mitigate the risks associated with shingles, vaccination is recommended, particularly for older adults. This article explores whether WellCare Part D covers the cost of the shingles vaccine.
Understanding Shingles and Its Vaccine
Shingles can be a debilitating condition, especially for older adults and those with weakened immune systems. The vaccine is an effective preventive measure. Two vaccines are commonly used in the United States: Zostavax and Shingrix.
- Zostavax: A live attenuated vaccine given as a single injection, primarily for adults aged 60 and older. It reduces the risk of developing shingles by about 51% and PHN by 67%.
- Shingrix: A newer, recombinant vaccine given in two doses, separated by 2 to 6 months. It is recommended for adults aged 50 and older and is over 90% effective in preventing shingles and PHN.
Medicare Part D and Vaccine Coverage
Medicare Part D is a prescription drug plan that helps cover the cost of medications, including some vaccines. Each Medicare drug plan has its own formulary, which is a list of covered drugs. The formulary is divided into tiers, which categorize drugs based on their cost. Typically, vaccines fall under the category of preventive medications and are covered by Medicare Part D.
WellCare Part D Coverage
WellCare is a prominent provider of Medicare Advantage plans and standalone Medicare Part D prescription drug plans. The coverage for the shingles vaccine under WellCare Part D depends on the specific plan and formulary.
Formulary Inclusion
Both Shingrix and Zostavax are generally included in the formularies of WellCare Part D plans. However, the tier and the associated copayment or coinsurance can vary.
- Shingrix: Due to its higher efficacy, Shingrix is more commonly recommended and covered. It is typically found in Tier 3 (preferred brand-name drugs) or Tier 4 (non-preferred brand-name drugs), with associated copayments or coinsurance.
- Zostavax: Although still available, Zostavax is less commonly used and may be placed in a higher tier with higher out-of-pocket costs.
Costs and Out-of-Pocket Expenses
The cost-sharing structure of WellCare Part D plans includes deductibles, copayments, and coinsurance. Here’s how these components might affect the cost of the shingles vaccine:
- Deductible: Some WellCare Part D plans have an annual deductible that must be met before the plan starts to pay. If the vaccine is received before meeting the deductible, the full cost may be out-of-pocket.
- Copayment/Coinsurance: After meeting the deductible, the plan pays a portion of the cost, while the beneficiary pays the remainder as a copayment (a fixed amount) or coinsurance (a percentage of the cost). The specific amount depends on the tier placement of the vaccine.
- Coverage Gap (Donut Hole): If the total drug costs exceed a certain limit, the beneficiary enters the coverage gap phase, where they may pay a higher percentage of the cost. For the shingles vaccine, this could mean higher out-of-pocket expenses until reaching the catastrophic coverage phase.
Examples of Plan Variability
To illustrate, let’s consider two hypothetical WellCare Part D plans:
Plan A:
- Annual Deductible: $250
- Shingrix Tier: 3 (Preferred Brand)
- Copayment: $40 per dose
- Zostavax Tier: 4 (Non-Preferred Brand)
- Copayment: $75 per dose
Plan B:
- No Annual Deductible
- Shingrix Tier: 2 (Generic/Preferred Brand)
- Copayment: $20 per dose
- Zostavax Tier: 3 (Preferred Brand)
- Copayment: $50 per dose
In Plan A, the beneficiary would pay $250 to meet the deductible before paying $40 per dose for Shingrix. In Plan B, without a deductible, the cost is $20 per dose immediately. These examples highlight the importance of reviewing specific plan details.
SEE ALSO: Does Traditional Medicine Cover the Shingles Vaccine?
Steps to Confirm Coverage
Beneficiaries should follow these steps to confirm coverage for the shingles vaccine under their WellCare Part D plan:
- Review the Formulary: Access the plan’s formulary online or request a printed copy. Look for Shingrix and Zostavax to determine their tier placement.
- Contact Customer Service: Call the customer service number on the back of the WellCare insurance card to ask specific questions about vaccine coverage, costs, and preferred pharmacies.
- Consult with Pharmacists: Visit a network pharmacy to inquire about the cost and coverage of the shingles vaccine under the specific WellCare plan.
- Check for Additional Benefits: Some WellCare plans may offer additional benefits or discounts for preventive services, including vaccinations.
Conclusion
WellCare Part D plans generally cover the shingles vaccine, with coverage details depending on the specific plan’s formulary and tier structure. Beneficiaries should review their plan’s formulary, contact customer service, and consult with pharmacists to understand their out-of-pocket costs and ensure they receive the vaccine at the most affordable rate. Given the high efficacy of the shingles vaccine, particularly Shingrix, and the potential complications from shingles, getting vaccinated is a wise preventive measure for eligible individuals.
Related Topics:
